With Bloomberg BNA's pharmaceuticals law publications, you can stay informed of the latest regulatory, legislative, and litigation developments affecting the pharmaceuticals industry. Follow major actions at the federal and state level that focus on intellectual property/patent issues, drug pricing and reimbursement, FDA oversight, and Federal Trade Commission antitrust enforcement.